Silvie Sharfuddin Email & Phone Number

New England

-Focus on commercial KOL relationship engagement-Promotional speaker training and development-Support the execution of promotional patient programs-Cross-functional team collaboration to provide key customer insights and input on strategy, tactics, messaging, and program execution

New Haven, Connecticut

• Developed and executed new marketing initiative, TMA Centers of Excellence, resulting in 16 successful collaborative meetings with target institutions and increasing access and aHUS patient identification at these accounts.• Led development and execution of 2016, 2017, and 2018 aHUS short and long term HCP strategic and tactical plans, increasing aHUS growth in demand and retention.• Close collaboration and matrix management of Cross-Functional Teams, including monitoring KPI and activities, addressing opportunities/challenges, working with leaders to course-correct.• Created tools for Cross-Functional Teams to meet their needs and brand strategies including: Diagnostic Liaisons, Clinical Specialists, Market Access, Case Managers, and Patient Advocacy.• Created and spearheaded 2017 Apheresis Strategy, consisting of new speaker deck creation, new speaker ID, ASFA Guidelines Tool creation and field launch, and coordinating marketing driven Apheresis Speaker Tour throughout US.• Improved US patient retention, re-launching aHUS patient segmentation strategy by training cross-functional teams at regional meetings and NSM, uncovering and leveraging patient characteristics and implementing genetic testing strategy, improving overall patient profiling capture to 87%.• Collaborated with Global aHUS Marketing team and developed materials for HCP messaging: updated ‘Genetic testing brochure’, ‘Patient Retention Brochure,’ including biomarker publication• Led field facing insight gathering events through aHUS Regional Market Champions; insights critical to adjustments to genetic testing, demand, retention, and lead generating strategies.• Collaborated with training team implementing current strategies and resources at various phase training classes.• Led key aHUS Congresses, increasing aHUS target customer reach and education measured by booth and ancillary sponsorship attendance and post congress patient ID.

• Exceeded expectations in patient identification and treatment in both PNH and aHUS disease states in 2014 and achieved the highest number of ships in the New England Region for aHUS in 2013.• Understand the driving factors that physicians face in their diagnostic and treatment decisions in the hematology and nephrology markets.• Educated physicians on how to diagnose and treat patients with two ultra-rare diseases, aHUS and PNH in the community, large practice and academic settings. • Manage targeted regional partnerships with RCS, DLS, Medical, One Source, Marketing, to increase patient ID, patient retention, and effectively resolve customer issues.• Mentored newly hired colleagues to increase their disease knowledge in the ultra-rare market and how to navigate between the various specialties to optimize patient identification, treatment, and retention.• Partnered with US Marketing team as the Regional aHUS Market Champ to provide insight and feedback on various marketing tools and resources.

• Successfully launched multiple oncology products including Sylatron for melanoma, Zolinza for CTCL, and Emend for CINV; top Regional Sylatron sales for multiple quarters in a territory without melanoma KOL.• Regional melanoma trainer and marketing liaison for various marketing initiatives – resource feedback and patient education material development.• Inducted into the Hall of Fame for being a 4 time Vice-President’s Club Award winner – top 5% of sales force. • Received numerous Awards of Excellence for consistent high sales since launch of Emend, Zolinza, and Sylatron.• Developed product advocates, openly collaborated and integrated with specialty representatives as well as extended hospital teams.• Successfully established a new customer base, educating the Oncology community on disease and initiating sales in a newly created oncology division. • Resolved many managed care and reimbursement issues in the oncology market to increase product access to target customers.• Leveraged marketing, training, and cross-functional resources based on strategic territory analysis.

• Product responsibilities included Zocor, Cozaar/Hyzaar, and Vioxx for geography with $15 million in yearly sales and 25 % average yearly growth. Regional share exceeded national average in Lipid, Anti-hypertensive, and Arthritis & Anti-inflammatory. Actively utilized Information Systems to analyze product trend information.• Developed and utilized key advocates and speakers by implementing Merck medical forum programs on a cluster and district level.• Drove Zocor and Vioxx product demand by achieving exclusive formulary status in key community hospitals. From 1999-2002, increased dollar value of ownership hospitals 460% and increased market share in these hospitals 400%.• Worked with Medical Boards to set up Grand Rounds for Zocor and Cozaar/Hyzaar. Brought in local, regional and national speakers for the CME accredited presentations as well as the departmental meetings.

Mba, Marketing And Management

Bachelor Of Science (B.S.), Mathematics, Business, Studio Art